Molecular cytogenetic aberrations in CD30+ anaplastic large cell lymphoma cell lines

被引:12
|
作者
Gogusev, J
Telvi, L
Nezelof, C
机构
[1] Hop Necker Enfants Malad, INSERM U507, F-75015 Paris, France
[2] Hop St Vincent de Paul, Grp Pathol Pediat, Lab Cytogenet, F-75674 Paris, France
关键词
D O I
10.1016/S0165-4608(02)00589-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anaplastic large cell lymphomas (ALCL) in children represent a heterogeneous group of neoplasms with regard to the cell lineages involved. The chromosomal 5q35 breakpoint (bp) and the expression of the NPM/ALK fusion gene are the most remarkable molecular cytogenetic features of these malignancies. To identify new locations of ALCL-related oncogenes, comparative genomic hybridization (CGH) was applied to three ALCL cell lines (SU-DHL-1, Karpas 299, and DEL) exhibiting the 5q35 bp and expressing the NPM/ALK transcript. The CGH profiles were compared with those obtained with DNA from U937, HL-60 cells, and altered lymph nodes from two children with ALCL. Significant DNA copy number gains and/or losses were observed on several chromosomes in all ALCL cell lines. Distinct amplicons were detected on 1q21similar toq44 (DEL), 7q12 (SU-DHL-1), and 1q12similar toq22 (Karpas 299) regions. The NPM/ALK fusion gene was confirmed by fluorescence in situ hybridization (FISH) analysis in more than 80% of interphase nuclei and metaphase spreads. Enhanced expression of TGF-beta2 and c-MET candidate genes located at the amplified regions was revealed in DEL and SU-DHL1 cell lines by Northern blot analysis. These findings delineate chromosomal imbalances in ALCL-derived cell lines in parallel with high level of amplification covering target DNA sequences, which could play a role in ALCL pathogenesis. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 50 条
  • [41] Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30+ Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients
    Wang, Di
    Xiao, Yi
    Li, Chunrui
    Wang, Na
    Huang, Liang
    Zhang, Yicheng
    Zhang, Tongcun
    Zhou, Jianfeng
    BLOOD, 2018, 132
  • [42] Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL)
    Mencia-Gutierrez, Enrique
    Gutierrez-Diaz, Esperanza
    Salamanca, Javier
    Martinez-Gonzalez, Miguel A.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (06) : 766 - 769
  • [43] LYMPHOHISTIOCYTIC T-CELL LYMPHOMA (ANAPLASTIC LARGE CELL LYMPHOMA CD30+/KI-1+ WITH A HIGH CONTENT OF REACTIVE HISTIOCYTES)
    PILERI, S
    FALINI, B
    DELSOL, G
    STEIN, H
    BAGLIONI, P
    POGGI, S
    MARTELLI, MF
    RIVANO, MT
    MASON, DY
    STANSFELD, AG
    HISTOPATHOLOGY, 1990, 16 (04) : 383 - 391
  • [44] Anaplastic Large Cell (cd30+) T-lymphoma (alk-) In A Boy After Renal Transplantation
    Battelino, Nina
    Jazbec, Janez
    Gazic, Barbara
    Novljan, Gregor
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1759 - 1759
  • [45] Posttransplant CD30+ (Ki-1) anaplastic large cell lymphoma -: A case report and review of the literature
    Lee, LY
    Harpaz, N
    Strauchen, JA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2003, 127 (03) : 349 - 351
  • [46] Targeting CD30 in Anaplastic Large Cell Lymphoma
    Vadakara, Joseph
    Pro, Barbara
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (04) : 285 - 291
  • [47] CD30+ skin nodule following successful treatment of Stage IV anaplastic large cell lymphoma (ALCL)
    Appel, Burton
    Chow, Kar Fai
    Bhattacharyya, Pritish
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 90 - 91
  • [48] Targeting CD30 in Anaplastic Large Cell Lymphoma
    Joseph Vadakara
    Barbara Pro
    Current Hematologic Malignancy Reports, 2012, 7 : 285 - 291
  • [49] GROWTH AND DEVELOPMENT OF HUMAN ANAPLASTIC LARGE CELL LYMPHOMA (KI-1, CD30+) IN SCID MICE
    NGAN, BY
    BERGSTROM, S
    LABORATORY INVESTIGATION, 1993, 68 (01) : A124 - A124
  • [50] CD30+ large B cell lymphoma with anaplastic features and complete loss of B cell marker expression arising from follicular lymphoma
    Raess, Philipp W.
    Wang, Hao-Wei
    Pack, Svetlana D.
    Jaffe, Elaine S.
    HISTOPATHOLOGY, 2019, 75 (04) : 602 - 605